144 related articles for article (PubMed ID: 33515898)
1. MiR-325-3p mediate the CXCL17/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma.
Li L; Ji Y; Chen YC; Zhen ZJ
Cytokine; 2021 May; 141():155436. PubMed ID: 33515898
[TBL] [Abstract][Full Text] [Related]
2. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
[TBL] [Abstract][Full Text] [Related]
3. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
[TBL] [Abstract][Full Text] [Related]
4. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.
Du C; Lv Z; Cao L; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
J Transl Med; 2014 Sep; 12():259. PubMed ID: 25240815
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
Tang SJ; Yang JB
Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH
Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
[TBL] [Abstract][Full Text] [Related]
7. microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
Sun Y; Liu L; Xing W; Sun H
Cell Signal; 2021 Jul; 83():109982. PubMed ID: 33741494
[TBL] [Abstract][Full Text] [Related]
8. KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.
Ma YS; Wu TM; Qian B; Liu YS; Ding H; Fan MM; Liu JB; Yu F; Wang HM; Shi Y; Gu LP; Li L; Tian LL; Wang PY; Wang GR; Wu ZJ; Zou QF; Ling CC; Fu D
J Cell Mol Med; 2021 Apr; 25(8):4040-4052. PubMed ID: 33621431
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
[TBL] [Abstract][Full Text] [Related]
10. Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression.
Moh-Moh-Aung A; Fujisawa M; Ito S; Katayama H; Ohara T; Ota Y; Yoshimura T; Matsukawa A
Sci Rep; 2020 Jun; 10(1):10418. PubMed ID: 32591615
[TBL] [Abstract][Full Text] [Related]
11. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
[TBL] [Abstract][Full Text] [Related]
12. ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6.
Li Y; Jiang A
Cancer Biol Ther; 2020 Jul; 21(7):647-655. PubMed ID: 32420798
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma.
Liao Y; Wang C; Yang Z; Liu W; Yuan Y; Li K; Zhang Y; Wang Y; Shi Y; Qiu Y; Zuo D; He W; Qiu J; Guan X; Yuan Y; Li B
Theranostics; 2020; 10(12):5209-5224. PubMed ID: 32373208
[TBL] [Abstract][Full Text] [Related]
14. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.
Cui ZH; Shen SQ; Chen ZB; Hu C
World J Gastroenterol; 2014 May; 20(18):5493-504. PubMed ID: 24833879
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
17. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
20. microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A.
Luo C; Yin D; Zhan H; Borjigin U; Li C; Zhou Z; Hu Z; Wang P; Sun Q; Fan J; Zhou J; Wang X; Zhou S; Huang X
Cell Death Dis; 2018 May; 9(5):535. PubMed ID: 29749382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
